Jick S S, Vasilakis-Scaramozza C, Maier W C
Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, MA 02421, USA.
Epidemiology. 2001 Mar;12(2):229-34. doi: 10.1097/00001648-200103000-00016.
Prolonged exposure to inhaled corticosteroids among adults over 49 years old has been reported to increase cataract risk. Small-scale studies of inhaled steroid users suggest that no increased risk for children and young adults exists. To describe cataract risk among people with asthma who use inhaled corticosteroids relative to patients with asthma with no history of corticosteroid use, we conducted a retrospective observational cohort study of patients identified from the United Kingdom-based General Practice Database with a nested case-control analysis. Relative to patients who do not use corticosteroids, all inhaled corticosteroid users were at a marginally increased risk of cataract (RR = 1.3). Among individuals 40 years of age or older, the risk ratio increased with use of increasing numbers of inhaled corticosteroid prescriptions after controlling for diabetes mellitus, hypertension, and smoking history. This trend was not evident in those under age 40.
据报道,49岁以上成年人长期吸入皮质类固醇会增加患白内障的风险。对吸入类固醇使用者的小规模研究表明,儿童和年轻人不存在风险增加的情况。为了描述使用吸入性皮质类固醇的哮喘患者相对于无皮质类固醇使用史的哮喘患者的白内障风险,我们对从英国全科医疗数据库中识别出的患者进行了一项回顾性观察队列研究,并进行了巢式病例对照分析。与不使用皮质类固醇的患者相比,所有吸入皮质类固醇使用者患白内障的风险略有增加(相对风险 = 1.3)。在40岁及以上的个体中,在控制了糖尿病、高血压和吸烟史后,随着吸入皮质类固醇处方数量的增加,风险比也增加。这种趋势在40岁以下的人群中并不明显。